Literature DB >> 25831240

Intestinal Fatty Acid Binding Protein: A Sensitive Marker in Abdominal Surgery and Abdominal Infection.

Tobias M Bingold1, Katharina Franck2, Katharina Holzer3, Kai Zacharowski1, Wolf O Bechstein3, Heimo Wissing4, Bertram Scheller1.   

Abstract

BACKGROUND: Intestinal fatty acid binding protein (iFABP) is elevated in plasma by intestinal injury. We investigated the influence of surgical trauma and severe sepsis caused by abdominal and pulmonary infection on plasma iFABP concentrations.
METHODS: Seventy-nine patients were included in this prospective observational study: 31 patients before elective major abdominal surgery (EMS), 33 patients with severe sepsis on admission to the intensive care unit (ICU), and 15 healthy volunteers who served as controls. Blood samples were taken before and after surgery for a period up to 5 d.
RESULTS: Prior to surgery, EMS patients had increased iFABP concentrations in those patients with intestinal cancer compared with patients without intestinal cancer (217 pg/mL, interquartile range [IQR] I-III 100-369 pg/mL versus 79 pg/mL, IQR I-III: 0-182 pg/mL; p<0.01) and with controls (114 pg/mL, IQR I-III: 103-124 pg/mL; p<0.01). Surgical trauma increased iFABP levels in patients without intestinal cancer (240 pg/mL, IQR I-III 111-305 pg/mL; p<0.01). Within 24 h after surgery, iFABP levels decreased to normal values. Patients with severe sepsis of abdominal origin had elevated concentrations compared with controls (324 pg/mL [IQR I-III 0-649 pg/mL]; p=0.05); in patients with pneumonia, iFABP levels were not significantly increased. Discrimination between intestinal- and pulmonary-induced sepsis was low (area under the curve [AUC] 0.693; 95% confidence interval 0.512-0.874).
CONCLUSIONS: Surgical trauma and severe sepsis lead to elevated iFABP concentrations. However, intestinal malignant disease and in some patients severe sepsis caused by pneumonia also resulted in elevated iFABP concentrations. The results support the idea that epithelial injury of many causes leads to elevated concentrations of iFABP. The value of iFABP for differentiating pulmonary from intestinal sepsis is limited.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25831240     DOI: 10.1089/sur.2014.073

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  16 in total

1.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

2.  Screening and combining serum biomarkers to improve their diagnostic performance in the detection of intestinal barrier dysfunction in patients after major abdominal surgery.

Authors:  Can Kong; Shu-Min Li; Hua Yang; Wei-Dong Xiao; Yun-Yun Cen; Yi Wu; Wei-Ming Li; Da-Li Sun; Peng-Yuan Xu
Journal:  Ann Transl Med       Date:  2019-08

3.  Systemic symptoms in irritable bowel syndrome: An investigative study on the role of enterocyte disintegrity, endotoxemia and inflammation.

Authors:  Ragnhild Undseth; Arnold Berstad; Jørgen Valeur
Journal:  Mol Med Rep       Date:  2016-10-21       Impact factor: 2.952

4.  Near-infrared fluorescence image-guidance in anastomotic colorectal cancer surgery and its relation to serum markers of anastomotic leakage: a clinical pilot study.

Authors:  Jacqueline van den Bos; Audrey C H M Jongen; Jarno Melenhorst; Stéphanie O Breukink; Kaatje Lenaerts; Rutger M Schols; Nicole D Bouvy; Laurents P S Stassen
Journal:  Surg Endosc       Date:  2019-02-01       Impact factor: 4.584

5.  I-FABP is decreased in COVID-19 patients, independently of the prognosis.

Authors:  Kevin Guedj; Mathieu Uzzan; Damien Soudan; Catherine Trichet; Antonino Nicoletti; Emmanuel Weiss; Hana Manceau; Alexandre Nuzzo; Olivier Corcos; Xavier Treton; Katell Peoc'h
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

6.  Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease.

Authors:  Stepan Coufal; Alena Kokesova; Helena Tlaskalova-Hogenova; Jiri Snajdauf; Michal Rygl; Miloslav Kverka
Journal:  J Immunol Res       Date:  2016-03-24       Impact factor: 4.818

7.  The intestinal fatty acid-binding protein as a marker for intestinal damage in gastroschisis.

Authors:  Alena Kokesova; Stepan Coufal; Barbora Frybova; Miloslav Kverka; Michal Rygl
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

8.  High expression of FABP4 and FABP6 in patients with colorectal cancer.

Authors:  Yaqin Zhang; Xiaotong Zhao; Lili Deng; Xueting Li; Ganbiao Wang; Yongxing Li; Mingwei Chen
Journal:  World J Surg Oncol       Date:  2019-10-24       Impact factor: 2.754

9.  Urinary I-FABP, L-FABP, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease.

Authors:  Stepan Coufal; Alena Kokesova; Helena Tlaskalova-Hogenova; Barbora Frybova; Jiri Snajdauf; Michal Rygl; Miloslav Kverka
Journal:  J Immunol Res       Date:  2020-03-03       Impact factor: 4.818

10.  Urinary liver-type fatty acid-binding protein variation as a predictive value of short-term mortality in intensive care unit patients.

Authors:  Ginga Suzuki; Ryo Ichibayashi; Saki Yamamoto; Hibiki Serizawa; Yoshimi Nakamichi; Masayuki Watanabe; Mitsuru Honda
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.